Patient advocate Andrew Schorr welcomes pharma's efforts to listen to, and work with, patients and calls for company-wide support for these new initiatives.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
